Dr. Peter Attia

Nobody can even invest a quarter of what we invest in this.

So we just have to acknowledge that that's a good thing. And yeah, it still makes some mistakes. So the majority of people who are conducting this research are good people. They have varying degrees of competence and varying blind spots. But for the most part, when...

So we just have to acknowledge that that's a good thing. And yeah, it still makes some mistakes. So the majority of people who are conducting this research are good people. They have varying degrees of competence and varying blind spots. But for the most part, when...

So we just have to acknowledge that that's a good thing. And yeah, it still makes some mistakes. So the majority of people who are conducting this research are good people. They have varying degrees of competence and varying blind spots. But for the most part, when...

multiple different labs over multiple decades conduct multiple types of trials and the answers largely point in the same direction, you're sort of inclined to think that there's probably not much of a signal in the other direction. Now, when it comes to pharmaceutical stuff, There's a different pathway, right?

multiple different labs over multiple decades conduct multiple types of trials and the answers largely point in the same direction, you're sort of inclined to think that there's probably not much of a signal in the other direction. Now, when it comes to pharmaceutical stuff, There's a different pathway, right?

multiple different labs over multiple decades conduct multiple types of trials and the answers largely point in the same direction, you're sort of inclined to think that there's probably not much of a signal in the other direction. Now, when it comes to pharmaceutical stuff, There's a different pathway, right?

So here, pharma does need to pay independent investigators to do research because of the regulatory pathway to get drugs approved. Now, we might see in the new administration a revision of how some of that is done. I think that there have been mistakes that have been made in the way drugs are approved. I don't think it's nefarious. I don't think it's a conspiracy.

So here, pharma does need to pay independent investigators to do research because of the regulatory pathway to get drugs approved. Now, we might see in the new administration a revision of how some of that is done. I think that there have been mistakes that have been made in the way drugs are approved. I don't think it's nefarious. I don't think it's a conspiracy.

So here, pharma does need to pay independent investigators to do research because of the regulatory pathway to get drugs approved. Now, we might see in the new administration a revision of how some of that is done. I think that there have been mistakes that have been made in the way drugs are approved. I don't think it's nefarious. I don't think it's a conspiracy.

People are very quick to attribute conspiracy to what I think is more readily attributable to incompetence at times, truthfully, or just people acting in their own best interest, right? Like, you know, water always follows the path of least resistance. So just because water goes down there doesn't mean like, oh, there's a conspiracy that the water is going down there.

People are very quick to attribute conspiracy to what I think is more readily attributable to incompetence at times, truthfully, or just people acting in their own best interest, right? Like, you know, water always follows the path of least resistance. So just because water goes down there doesn't mean like, oh, there's a conspiracy that the water is going down there.

People are very quick to attribute conspiracy to what I think is more readily attributable to incompetence at times, truthfully, or just people acting in their own best interest, right? Like, you know, water always follows the path of least resistance. So just because water goes down there doesn't mean like, oh, there's a conspiracy that the water is going down there.

No, like that's what gravity and less resistance means. So... As one example, I think that there should probably be fewer barriers during the lead up to approval, but more barriers post-approval. In other words, I'll give you one example. It's a controversial example, but I feel strongly about it. Paxlovid was a drug that was approved to treat people with COVID, right?

No, like that's what gravity and less resistance means. So... As one example, I think that there should probably be fewer barriers during the lead up to approval, but more barriers post-approval. In other words, I'll give you one example. It's a controversial example, but I feel strongly about it. Paxlovid was a drug that was approved to treat people with COVID, right?

No, like that's what gravity and less resistance means. So... As one example, I think that there should probably be fewer barriers during the lead up to approval, but more barriers post-approval. In other words, I'll give you one example. It's a controversial example, but I feel strongly about it. Paxlovid was a drug that was approved to treat people with COVID, right?

This was a drug, I believe it's a Pfizer drug. So if you got COVID, they would give you Paxlovid. And it was approved very quickly. But I think ask any doctor who's been prescribing Paxlovid for patients with COVID, the drug doesn't work. Like, it just outright doesn't work. And by the way, it might even increase your risk of getting subsequent COVID.

This was a drug, I believe it's a Pfizer drug. So if you got COVID, they would give you Paxlovid. And it was approved very quickly. But I think ask any doctor who's been prescribing Paxlovid for patients with COVID, the drug doesn't work. Like, it just outright doesn't work. And by the way, it might even increase your risk of getting subsequent COVID.

This was a drug, I believe it's a Pfizer drug. So if you got COVID, they would give you Paxlovid. And it was approved very quickly. But I think ask any doctor who's been prescribing Paxlovid for patients with COVID, the drug doesn't work. Like, it just outright doesn't work. And by the way, it might even increase your risk of getting subsequent COVID.

And while I can appreciate why the FDA wanted to see that drug approved quickly because of the way the world looked then, and especially if you're trying to treat people who are uniquely vulnerable to COVID, which would primarily be older people,